Oxymap
PrivateTotal Funding Raised
$386,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Oxymap operates in Healthcare & Life Sciences and is based in Iceland. It has raised $386,000.
Oxymap is a medical technology company that develops and markets non-invasive retinal oximetry devices and software for eye-care professionals and clinical researchers.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oxymap Comparables
Compare Oxymap with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zilia | 83% | |
| Imedos Systems GmbH | 80% | |
| RetinaLyze System A/S | 71% |
For institutional investors. Book with your work email.
Oxymap Funding Rounds
Historical fundraising activity
Oxymap Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rannís - The Icelandic Centre for Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 83% MoM.
- Jul 3, 2025
Monthly visitors increased 125% MoM, reaching 304.
For institutional investors. Book with your work email.
Oxymap Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oxymap's valuation, stock price, and market status.
Is Oxymap a public or private company?
Oxymap is a private company.
What is the current stock price of Oxymap?
Oxymap is a private company, so its shares have no public market price. Caplight tracks Oxymap's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Oxymap worth (valuation)?
Valuation information for Oxymap is not publicly available.
Can I buy Oxymap stock?
Oxymap shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Oxymap's last funding round?
Funding round information for Oxymap is not publicly available.
Who are the main investors in Oxymap?
Key investors in Oxymap include Rannís - The Icelandic Centre for Research.
Will Oxymap IPO soon?
No public IPO plans have been announced for Oxymap.
How can I track Oxymap secondary market activity?
Caplight tracks bids, offers, and trades in Oxymap's shares on secondary markets.